Clinical trials
Toxicity clinical trials
Below are recruiting toxicity clinical trials, each written for real people, not researchers. We’re tracking 208 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06640959Recruiting
Bowel health study for prostate cancer radiation
This study tests whether a daily drink can help reduce bowel side effects caused by radiation for prostate cancer. If you are about to start radiation for intermediate to high-risk prostate cancer, you may be able to join.
Manchester, Greater ManchesterAges 18 years+ - NCT06760806Recruiting
Side effects of palliative radiotherapy study
This study looks at side effects in patients receiving palliative radiotherapy (radiation to relieve symptoms from cancer). It may help doctors better understand how to manage these side effects.
BolognaAges 18 years+ - NCT06765252Recruiting
How gene differences affect capecitabine side effects
This study looks at how genetic differences in Egyptian people with breast or colorectal cancer might affect the side effects of the chemotherapy drug capecitabine. The goal is to understand why some people have more side effects than others.
Shibīn al Kawm, MenoufiaAges 18 years+ - NCT06774482Recruiting
Comparing radiation treatments for uterine cancer
This study looks back at patients treated with radiation for uterine cancer at Sant'Orsola Polyclinic in Bologna to compare different treatment options and see which ones work best and cause fewer side effects.
BolognaAges 18 years+ - NCT07485608Recruiting
Reducing lead dust in older homes
This study tests whether cleaning and other methods can lower lead dust in homes built before 1978. It may help protect your child from lead exposure.
East Lansing, MichiganAges Up to 7 years - NCT07473271Enrolling by invitation
Vaginal therapy devices after pelvic radiation
This trial tests special exerciser and irrigation devices to help with vaginal recovery after pelvic radiation. It may help reduce side effects like narrowing or dryness.
Beijing, Beijing MunicipalityAges 18–70 - NCT07476807Enrolling by invitation
Using video calls to check skin reactions from cancer treatment
This study tests if video consultations can safely check skin side effects from chemotherapy or other cancer drugs. If you have a mild to moderate skin rash or reaction, you might be able to have a telemedicine visit instead of going to the hospital.
Sligo, SligoAges Any age - NCT07463274Enrolling by invitation
Simulation training for managing numbing medicine toxicity in surgical residents
This trial tests a simulation training program to help surgical residents (non-anesthesiologists) recognize and manage a rare but serious reaction to numbing medicine called local anesthetic systemic toxicity. Participation involves a team practice session to improve emergency readiness.
KonyaAges 18–40 - NCT07456592Recruiting
A test to detect toxic herbs in urine for aconite poisoning
This trial is testing a new device that can quickly detect poisonous Chinese herbs, like aconite, in a person's urine. It may help doctors diagnose poisoning faster and more easily.
Hong KongAges 18 years+ - NCT07435623Recruiting
Long-term side effects of radiation for cervical and endometrial cancers
This study looks at late side effects in patients who had radiation therapy after surgery for cervical or endometrial cancer. Understanding these effects can help improve future care.
Mumbai, MaharashtraAges 18–75 - NCT07410689Recruiting
A chatbot to help with cancer costs for rural patients
This study is testing a chatbot that gives personalized financial advice to help people with cancer manage the costs of their care. It is designed for patients or caregivers who live in rural areas of Utah, Idaho, Wyoming, Montana, or Nevada.
Salt Lake City, UtahAges 18 years+ - NCT06531681Recruiting
Precision radiotherapy with MRI-guided technology
This trial tests a new type of radiotherapy that uses MRI scans to guide the radiation beam more precisely. It aims to treat tumors while reducing damage to healthy tissue.
HaikouAges 18–75 - NCT06826534Recruiting
At-home heart rehab for teens with heart failure risk
This study tests if a home-based exercise program using a Fitbit can help teens who had chemotherapy improve their heart and lung fitness. You would exercise at home, track your activity, and have monthly virtual check-ins for 6 months.
Los Angeles, CaliforniaAges birth–21 years - NCT03417336Recruiting
Radiation for prostate cancer using smaller, targeted doses
This trial studies a specific radiation schedule for prostate cancer (with an extra “boost” dose) and checks whether it works well and is tolerable. It may help people with higher-risk, localized prostate cancer by aiming at the cancer while limiting side effects to surrounding tissues.
DijonAges 18–85 - NCT06829472RecruitingPhase 3
Comparing melphalan doses before stem cell transplant for AML/MDS
This trial compares two different doses of a chemotherapy drug (melphalan) as part of the conditioning treatment before a stem cell transplant. The goal is to find which dose is safer and more effective for people with AML or MDS.
Shanghai, Shanghai MunicipalityAges 18–55 - NCT07382752Recruiting
Studying immunotherapy side effects and cancer response
This study looks at how your body responds to immunotherapy and how to manage side effects. It aims to separate the treatment's benefits from its unwanted reactions.
Houston, TexasAges 18 years+ - NCT07381634RecruitingPhase 2
Testing ondansetron to reduce immunotherapy side effects in liver cancer
This study tests whether adding ondansetron (a common anti-nausea drug) can reduce side effects from immunotherapy in people with liver cancer. If you are starting a specific combination treatment for liver cancer, you may be eligible.
Wenzhou, ZhejiangAges 18–80 - NCT07388407Recruiting
Genetics of leflunomide for rheumatoid arthritis
This study looks at how your genes might affect how well leflunomide works for rheumatoid arthritis. It is for Pakistani adults who are starting or recently started leflunomide, and will help doctors understand who might respond best.
Islamabad, Punjab ProvinceAges 20–65 - NCT07371585RecruitingPhase 2
Trastuzumab Deruxtecan for first-line HER2-positive advanced breast cancer
This trial tests a targeted therapy called Trastuzumab Deruxtecan (T-DXd) for people with HER2-positive breast cancer that has spread or cannot be removed. It is for those who have not yet received any chemotherapy or HER2-targeted treatment for metastatic disease. The study also focuses on managing side effects early, using digital tools to track symptoms.
VillejuifAges 18 years+ - NCT04902846Recruiting
Checking kidney side effects from immune cancer medicines
This study looks at how immune checkpoint medicines (sometimes combined with other treatments like chemotherapy) may affect the kidneys. It may help doctors better prevent or manage kidney side effects in people starting these therapies.
SalamancaAges 18–100 - NCT07354165Recruiting
Financial burden in early breast cancer patients
This study looks at the financial challenges people with early-stage breast cancer face during treatment. Researchers want to understand how costs affect patients so they can find ways to help.
NaplesAges Any age - NCT07357636Recruiting
Immune therapy side effects study for solid tumors
This study looks at side effects from immune checkpoint inhibitors in people with solid tumors. It aims to understand why side effects happen and who might be at risk, so doctors can better manage them.
Fuzhou, FujianAges 18 years+ - NCT05652673Recruiting
Stopping immunotherapy after a good melanoma response
This trial studies whether it’s safe to stop nivolumab (an immunotherapy) after your melanoma has responded well to initial treatment with ipilimumab plus nivolumab. It may help some people avoid ongoing treatment side effects while still keeping the cancer controlled.
RotterdamAges 18 years+ - NCT06664528Recruiting
Heart health study for adults getting certain chemo
This study tracks the heart health of adults receiving chemotherapy that may affect the heart. It helps doctors understand how to better monitor and protect patients.
Rome, LazioAges 18 years+
Hear when a new Toxicity trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for toxicity?
- Yes. Clin2 currently lists 208 recruiting toxicity studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a toxicity trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a toxicity trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.